Review
Copyright ©The Author(s) 2020.
World J Gastroenterol. Apr 14, 2020; 26(14): 1580-1593
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1580
Table 4 List of approved drugs targeting immune checkpoints for gastrointestinal cancers
TargetDrugCommercial nameIndication
PD-1NivolumabOpdivoHepatocellular carcinoma, colorectal cancer with MSI-H
PD-1PembrolizumabKeytrudaGastric cancer, hepatocellular carcinoma, colorectal cancer, solid tumors with MSI-H
CTLA-4 and PD-1Ipilimumab plus nivolumabYervoy plus OpdivoColorectal cancer with MSI-H